Tetany, hypomagnesemia, and proton-pump inhibitors.
Giuseppe
G
Famularo
Giovanni
G
Minisola
Maria Cristina
MC
Bravi
Pasquale
P
Colucci
Laura
L
Gasbarrone
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D007011:Hypoparathyroidism / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D008274:Magnesium / Q000097:blood; D008275:Magnesium Deficiency / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects*; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D013746:Tetany / Q000209:etiology*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D015415:Biomarkers; D054328:Proton Pump Inhibitors; D000077402:Pantoprazole; D008274:Magnesium; D009853:Omeprazole